Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA
- 18 November 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 415 (2), 325-329
- https://doi.org/10.1016/j.bbrc.2011.10.055
Abstract
No abstract availableKeywords
Funding Information
- Methodist Research Institute, Indiana University Health
This publication has 26 references indexed in Scilit:
- Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signalingInternational Journal of Oncology, 2011
- Inhibitory Effects of Ganoderma lucidum on Tumorigenesis and Metastasis of Human Hepatoma Cells in Cells and Animal ModelsJournal of Agricultural and Food Chemistry, 2009
- Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese womenInternational Journal of Cancer, 2008
- Lucidenic Acid B Induces Apoptosis in Human Leukemia Cells via a Mitochondria-Mediated PathwayJournal of Agricultural and Food Chemistry, 2008
- The anti-invasive effect of lucidenic acids isolated from a newGanoderma lucidum strainMolecular Nutrition & Food Research, 2007
- Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF- B and AP-1Carcinogenesis: Integrative Cancer Research, 2007
- CDC20, a potential cancer therapeutic target, is negatively regulated by p53Oncogene, 2007
- Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cellsLife Sciences, 2006
- Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cellsLife Sciences, 2005
- Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cellsOncogene, 2005